1-3 of 3
Vito Sabato, MD
Close
Sort by
Journal Articles

Pioneer Part 2: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate Safety and Efficacy of Avapritinib in Indolent Systemic Mastocytosis

Cem Akin, MDPhD, Hanneke Oude Elberink, MD PhD, Jason Gotlib, MD MS, Vito Sabato, MD PhD, Karin Hartmann, MD, Sigurd Broesby-Olsen, MD, Mariana Castells, MD PhD, Tsewang Tashi, MD, Mark L Heaney, MD, Tracy I. George, MD, Frank Siebenhaar, MD, Deepti H. Radia, MRCPI, FRCPath, Massimo Triggiani, MD PhD, Paul van Daele, MD, Daniel J. DeAngelo, MD PhD, Iván Alvarez-Twose, MD PhD, Andreas Reiter, MD, Peter Vadas, MD PhD, Patrizia Bonadonna, MD, Paggy Hew, MS, Hui-Min Lin, PhD, Maria Roche, MS, Marcus Maurer, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 41–42.
https://doi.org/10.1182/blood-2020-136632
Published: 2020
Journal Articles

Distinct Diagnostic and Clinical Features of Bone Marrow Mastocytosis: A Study of the Registry of the European Competence Network on Mastocytosis (ECNM)

Massimiliano Bonifacio, MD, Patrizia Bonadonna, MD, Hanneke Oude Elberink, MD, Björn van Anrooij, MD, Aleksandra Górska, MD, Magdalena Lange, MD, Emir Hadzijusufovic, DVM, Luigi Scaffidi, Ilaria Tanasi, MD, Cecelia Perkins, Virginia Valeria Ferretti, Anja Illerhaus, PhD, Thilo Jakob, MD, Roberta Parente, MD, Mohamad Jawhar, MD, Francesca Caroppo, MD, Alexander Zink, MD, Alex Kilbertus, MD, Akif Selim Yavuz, MD, Michael Doubek, MD PhD, Hans Hagglund, MD PhD, Jens P. Panse, MD, Vito Sabato, MD PhD, Elisabeth Aberer, MD, Nadja Jaekel, MD, Peter Vandenberghe, MD PhD, David Fuchs, MD, Knut Brockow, MD, Anna Belloni Fortina, MD, Andreas Reiter, MD, Massimo Triggiani, MD, Khalid Shoumariyeh, MD, Karin Hartmann, MD, Chiara Elena, Olivier Hermine, MD PhD, Jason Gotlib, MD, Marek Niedoszytko, MD, Hanneke Kluin-Nelemans, MD PhD, Wolfgang R. Sperr, MD, Peter Valent, MD, Roberta Zanotti, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4200.
https://doi.org/10.1182/blood.V130.Suppl_1.4200.4200
Published: 2017
Journal Articles

Prognostic Factors and Survival Prediction in 1,088 Patients with Mastocytosis Collected in the Registry of the European Competence Network on Mastocytosis (ECNM Registry)

Wolfgang R. Sperr, MD, Michael Kundi, MD, Hanneke Oude Elberink, MD, Björn van Anrooij, MD, Karoline V Gleixner, MD, Emir Hadzijusufovic, DVM, Aleksandra Górska, MD, Magdalena Lange, MD, Anja Rabenhorst, PhD, Serena Merante, MD, Chiara Elena, MD, Anna Belloni Fortina, MD, Elena Fontana, MD, Juliana Schwaab, MD, Mohamad Jawhar, MD, Roberta Zanotti, MD, Patrizia Bonadonna, MD, Massimo Triggiani, MD, Cecelia Perkins, MPH, Jason R. Gotlib, MD, Michael Doubek, Khalid Shoumaryeh, MD, David Fuchs, MD, Vito Sabato, MD, Knut Brockow, MD, Agnes Bretterklieber, MD, Nadja Jaekel, MD, Andreas Reiter, MD, Karin Hartmann, MD, Marek Niedoszytko, MD, Hanneke C. Kluin-Nelemans, MD PhD, Peter Valent, MD
Journal: Blood
Blood (2016) 128 (22): 396.
https://doi.org/10.1182/blood.V128.22.396.396
Published: 2016